SCHEMBL14367269

SCHEMBL14367269

CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)CS(=O)(=O)N1CCN(Cc2ccncc2)CC1)S(=O)(=O)c1ccc2c(c1)OCO2

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SPPL2A Q8TCT8 1/20 0.46
▸ ABCB1 P08183 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ MLNR O43193 1/20 0.41
▸ ABCB11 O95342 1/20 0.41
▸ CTSD P07339 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP3A5 P20815 1/20 0.41
▸ CNR1 P21554 1/20 0.41
▸ TBXAS1 P24557 1/20 0.41
▸ ADRA1A P35348 1/20 0.41
▸ BMP1 P13497 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14113277 0.96 SPPL2A (0.49) SPPL2AABCB1LMNAMLNRABCB11
SCHEMBL14113284 0.94 BMP1 (0.46) SPPL2AABCB1LMNAMLNRABCB11
SCHEMBL14367268 0.92 ABCB1 (0.44) SPPL2AABCB1LMNAMLNRABCB11
SCHEMBL14367270 0.90 SPPL2A (0.49) SPPL2AABCB1LMNAMLNRABCB11
SCHEMBL14338852 0.89 SPPL2A (0.48) SPPL2AABCB1LMNAMLNRABCB11
SCHEMBL14367267 0.88 SPPL2A (0.47) SPPL2AABCB1LMNAMLNRABCB11
SCHEMBL5632828 0.85 BMP1 (0.43) LMNABMP1
SCHEMBL14338882 0.85 SPPL2A (0.51) SPPL2AABCB1LMNAMLNRABCB11
SCHEMBL5403915 0.84 SPPL2A (0.53) SPPL2AABCB1LMNAMLNRABCB11
SCHEMBL5863507 0.82 SPPL2A (0.53) SPPL2AABCB1LMNAMLNRABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7297793-B2 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors G.D. SEARLE, LLC (US) 2007-11-20 — — US disclosed
US-7297793-B2 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors G.D. SEARLE, LLC (US) 2007-11-20 — — US disclosed
Send feedback